Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study evaluated the utility of the serum marker HE4 in distinguishing endometriosis from adnexal malignancies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis via openalex
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases via openalex
- Is CA72-4 a Useful Biomarker in Differential Diagnosis between Ovarian Endometrioma and Epithelial Ovarian Cancer? via openalex
- Serum CA-125 in preoperative patients at high risk for endometriosis via openalex
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- W2090081190 via openalex
- W2107678655 via openalex
- W2117275438 via openalex
- W4301023391 via openalex
- W6628435230 via openalex
- W6642265915 via openalex
- W6649668245 via openalex
- W6650361504 via openalex
- W161649893 via openalex
- W6656330334 via openalex
- W1967743734 via openalex
- W1975581154 via openalex
- W1997114009 via openalex
- W2061926168 via openalex
- W2070058128 via openalex
- W2078301618 via openalex
Cited by (8)
- The Diagnostic Value of the CA125 and Ultrasound Combination for Endometriosis: A Retrospective Cohort Study 2025
- The Search for Biomarkers in Endometriosis: a Long and Windy Road 2021
- The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis 2021
- Does the Use of the “Proseek® Multiplex Oncology I Panel” on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis? 2020
- Endometriomas with low-risk malignancy potential in ultrasonography with high human epididymis protein 4 and risk of ovarian malignancy algorithm: a cases series 2019
- Surgical challenges in the treatment of perimenopausal and postmenopausal endometriosis 2018
- Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report 2018
- Endometriosis-Search for Biomarkers 2016
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:33.600579+00:00
License: CC0
· commercial use OK